Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin

Clin Gastroenterol Hepatol. 2006 Sep;4(9):1082-9. doi: 10.1016/j.cgh.2006.04.010. Epub 2006 Jul 31.

Authors

American Gastroenterological Association¹; C Mel Wilcox, Jeroan Allison, Keith Benzuly, Marie Borum, Byron Cryer, Tilo Grosser, Richard Hunt, Uri Ladabaum, Angel Lanas, Harold Paulus, Carol Regueiro, Robert S Sandler, Lee Simon

Affiliation

¹ Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. melw@uab.edu

PMID: 16877048
DOI: 10.1016/j.cgh.2006.04.010

No abstract available

Publication types

Consensus Development Conference
Practice Guideline
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Aspirin / adverse effects
Aspirin / therapeutic use*
Cardiovascular Diseases / chemically induced
Cyclooxygenase 2 Inhibitors / adverse effects
Cyclooxygenase 2 Inhibitors / therapeutic use*
Gastrointestinal Diseases / chemically induced
Humans

Substances

Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase 2 Inhibitors
Aspirin